Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed May 14, 2018 · 10-Q · 44 days after period end · 0001144204-18-027804
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | -$2.30M | -$1.79M | -$1.79M | -$2.24M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 14, 2018 · 44 d after period end
